Walleye Capital
BOLD

Walleye Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History

Walleye Capital’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-27,310
Closed -$1.63M – 2049
2019
Q4 		$1.63M Buy
+27,310
New +$1.02M 0.11% 262

Walleye Capital's BOLD Position: Q1 2020 in Review

Walleye Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 27,310 shares — an estimated $1.63M sold.

Walleye Capital first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $1.63M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Walleye Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Walleye Capital sold 27,310 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.63M.
  • Walleye Capital first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Walleye Capital's Audentes Therapeutics, Inc position peaked at $1.63M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Walleye Capital's 13F filing for Q1 2020, filed 15 May 2020.